Palm Beach, FL, September 9, 2020 – The Now Corporation is pleased to announce that, pursuant to the press release dated August 24th, it has signed a joint venture with Hollywood Diagnostics Center to perform neurological studies using state-of-the-art imaging technology to measure brain activity by detecting changes associated with blood flow when CBD compounds are introduced to the human body. The goal of the imaging data analysis is to detect correlations between brain activation in subjects when either non-tasked or tasked activities are performed during the scan with CBD compounds present. It also aims to discover correlations with cognitive states after CBD compounds are introduced to the subject. The data derived from the studies will be published to the public via the National Institute of Health (NIH) database or any other public platforms within the scientific research community.

Hollywood Diagnostics Center is a leader in the medical diagnostics field while performing over 30,000 diagnostic procedures annually. The center continues to be at the forefront of medical technology by progressively updating its equipment and procedures to reflect the latest advances in medicine. HDC has provided the healthcare community with outstanding, technologically advanced medical services to address the changing needs of patients.

The parties desire to establish between them a joint venture in order to collaborate in:

A) Independent industry reviews and studies (United States and internationally)

B) Analysis and research that measures brain activity by detecting changes associated with blood flow using cannabinoids to determine changes in brain function.

C) Perform blood draw findings that go along with imaging analyses.

D) Publishing of White Papers to National Institute of Health, and other Scientific Publishing Platforms.

Updates will be forthcoming


The Now Corporation is a publicly traded, bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its acquired assets, The Now Corporation is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal cannabis, both in the United States and Canada. At The Now Corporation, we unlock and advance medicine for human life around the world, at every stage of life.

For further information, please contact:

Ken Williams
Chief Executive Officer
The Now Corporation

Legal Notice Regarding Forward-Looking Statements:

This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of The Now Corporation to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, The Now Corporation undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.